HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ryo Morimoto Selected Research

Adrenocortical Adenoma (Disease, Conn's)

11/2020Intratumoral heterogeneity of the tumor cells based on in situ cortisol excess in cortisol-producing adenomas; ∼An association among morphometry, genotype and cellular senescence∼.
6/2020The Effect of Extracellular Calcium Metabolism on Aldosterone Biosynthesis in Physiological and Pathological Status.
2/2020Unique Sex Steroid Profiles in Estrogen-Producing Adrenocortical Adenoma Associated With Bilateral Hyperaldosteronism.
1/201918-Oxocortisol Synthesis in Aldosterone-Producing Adrenocortical Adenoma and Significance of KCNJ5 Mutation Status.
1/2018Tumor microenvironment in functional adrenocortical adenomas: immune cell infiltration in cortisol-producing adrenocortical adenoma.
1/2016Expression of steroidogenic enzymes and their transcription factors in cortisol-producing adrenocortical adenomas: immunohistochemical analysis and quantitative real-time polymerase chain reaction studies.
5/2010Presence of kisspeptin-like immunoreactivity in human adrenal glands and adrenal tumors.
1/2009An analysis of potential surrogate markers of target-specific therapy in archival materials of adrenocortical carcinoma.
11/2007Localization of aldosterone-producing adrenocortical adenomas: significance of adrenal venous sampling.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ryo Morimoto Research Topics

Disease

40Adenoma (Adenomas)
02/2022 - 11/2007
33Hyperaldosteronism (Conn Syndrome)
01/2022 - 11/2007
27Neoplasms (Cancer)
01/2022 - 05/2008
9Hyperplasia
01/2021 - 02/2014
9Adrenocortical Adenoma (Disease, Conn's)
11/2020 - 11/2007
7Adrenocortical Carcinoma
01/2022 - 05/2008
5Hypertension (High Blood Pressure)
08/2021 - 12/2009
5Cushing Syndrome
01/2021 - 12/2011
5Pheochromocytoma
01/2020 - 05/2008
5Heart Failure
10/2019 - 05/2008
2Osteoporosis
06/2020 - 10/2019
2Essential Hypertension
05/2019 - 01/2017
2Melanoma (Melanoma, Malignant)
09/2017 - 03/2017
2Chronic Renal Insufficiency
05/2014 - 08/2009
2Inflammation (Inflammations)
02/2013 - 12/2009
2Renal Insufficiency (Renal Failure)
07/2010 - 12/2009
1Stroke (Strokes)
01/2021
1Ulcerative Colitis
01/2021
1Lung Diseases (Lung Disease)
01/2021
1Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
01/2021
1Cardiovascular Diseases (Cardiovascular Disease)
06/2020
1Hypocalcemia
06/2020
1Hypercalciuria
06/2020
1Metabolic Diseases (Metabolic Disease)
06/2020
1Hypogonadism (Hypergonadotropic Hypogonadism)
02/2020
1Paraganglioma (Paragangliomas)
01/2020
1Insulin Resistance
11/2019
1Germinoma
11/2019
1Morbid Obesity
11/2019
1Obesity
11/2019
1Combined Pituitary Hormone Deficiency
11/2019
1Craniopharyngioma (Craniopharyngiomas)
11/2019
1Cardiomyopathies (Cardiomyopathy)
10/2019
1Hypokalemia
01/2019
1Adrenocorticotropic hormone deficiency
03/2017
1Hypoglycemia (Reactive Hypoglycemia)
11/2016
1Neuroendocrine Tumors (Neuroendocrine Tumor)
11/2016
1Solitary Fibrous Tumors
11/2016
1Isolated Systolic Hypertension
03/2016

Drug/Important Bio-Agent (IBA)

42AldosteroneIBA
01/2022 - 11/2007
14Hydrocortisone (Cortisol)FDA LinkGeneric
02/2022 - 05/2008
9Cytochrome P-450 CYP11B2 (CYP11B2)IBA
01/2022 - 03/2014
7Messenger RNA (mRNA)IBA
01/2022 - 05/2008
6SteroidsIBA
01/2022 - 08/2011
6EnzymesIBA
01/2022 - 08/2014
6Adrenocorticotropic Hormone (ACTH)FDA Link
01/2021 - 04/2012
4Steroid 11-beta-Hydroxylase (11 beta-Hydroxylase)IBA
01/2022 - 01/2016
4Antihypertensive Agents (Antihypertensives)IBA
01/2021 - 08/2014
4Biological ProductsIBA
11/2020 - 07/2013
4Hormones (Hormone)IBA
02/2020 - 02/2013
4Oxidoreductases (Dehydrogenase)IBA
01/2016 - 02/2014
4Peptides (Polypeptides)IBA
10/2010 - 05/2008
318-oxocortisolIBA
01/2019 - 08/2011
3ReninIBA
01/2019 - 01/2017
3Angiotensin IIIBA
12/2014 - 08/2009
3Proteins (Proteins, Gene)FDA Link
12/2014 - 11/2013
3Prorenin ReceptorIBA
11/2013 - 08/2009
3AdrenomedullinIBA
07/2010 - 07/2008
3urotensin IIIBA
08/2009 - 05/2008
2CholesterolIBA
02/2022 - 01/2022
2nasIBA
01/2022 - 10/2019
2LipidsIBA
11/2020 - 02/2014
2CalciumIBA
06/2020 - 10/2019
2Estrogens (Estrogen)FDA Link
02/2020 - 01/2013
2CatecholaminesIBA
01/2020 - 05/2019
2GlucocorticoidsIBA
10/2019 - 11/2011
2NivolumabIBA
09/2017 - 03/2017
23 beta-hydroxysteroid dehydrogenase type IIIBA
01/2016 - 06/2015
2Protein Isoforms (Isoforms)IBA
06/2015 - 02/2014
2Monoclonal AntibodiesIBA
12/2014 - 02/2014
2Biomarkers (Surrogate Marker)IBA
08/2011 - 01/2009
2KisspeptinsIBA
10/2010 - 05/2010
1Calcium Channel Blockers (Blockers, Calcium Channel)IBA
01/2022
1Cholesterol Esters (Cholesteryl Esters)IBA
01/2022
1oxidized low density lipoproteinIBA
01/2022
1Cholesterol Side-Chain Cleavage Enzyme (CYP11A1)IBA
01/2022
1Amlodipine (Norvasc)FDA LinkGeneric
01/2022
1MelanocortinsIBA
01/2021
1Butylated Hydroxyanisole (BHA)IBA
01/2021
1ElectrolytesIBA
01/2021
1Dehydroepiandrosterone (DHEA)IBA
11/2020
1Parathyroid Hormone (Parathormone)IBA
06/2020
1Vitamin DFDA LinkGeneric
06/2020
1AndrogensIBA
02/2020
1Insulin (Novolin)FDA Link
11/2019
12- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA
05/2019
1Brain Natriuretic Peptide (Natrecor)FDA Link
01/2019
1AntibodiesIBA
09/2017
1Insulin-Like Growth Factor II (Somatomedin A)IBA
11/2016

Therapy/Procedure

12Adrenalectomy
08/2021 - 07/2011
6Therapeutics
01/2021 - 01/2009
2Lasers (Laser)
01/2022 - 01/2015
2Ligation
12/2009 - 05/2008
1Bariatric Surgery
11/2019
1Gastrectomy
11/2019
1Radiotherapy
11/2019
1Cesarean Section (Caesarean Section)
10/2019
1Heart Transplantation (Grafting, Heart)
01/2019
1Catheters
01/2017
1Pancreatectomy
11/2016